Corcept Therapeutics Incorporated (CORT) DCF Valuation

Corcept Therapeutics Incorporated (CORT) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Corcept Therapeutics Incorporated (CORT) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Streamline your analysis and improve precision with our (CORT) DCF Calculator! Equipped with up-to-date Corcept Therapeutics data and customizable assumptions, this tool enables you to forecast, analyze, and value (CORT) like a seasoned investor.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 306.5 353.9 366.0 401.9 482.4 528.0 577.9 632.5 692.3 757.7
Revenue Growth, % 0 15.46 3.42 9.8 20.04 9.45 9.45 9.45 9.45 9.45
EBITDA 113.8 130.4 124.5 112.6 108.3 167.3 183.2 200.5 219.4 240.2
EBITDA, % 37.12 36.86 34.01 28.03 22.46 31.7 31.7 31.7 31.7 31.7
Depreciation 2.2 2.2 3.1 3.0 1.0 3.3 3.6 4.0 4.3 4.7
Depreciation, % 0.70835 0.63215 0.83803 0.73882 0.21601 0.62667 0.62667 0.62667 0.62667 0.62667
EBIT 111.6 128.2 121.4 109.7 107.3 164.0 179.5 196.5 215.1 235.4
EBIT, % 36.41 36.23 33.17 27.29 22.24 31.07 31.07 31.07 31.07 31.07
Total Cash 315.3 476.9 335.8 436.6 368.2 494.3 541.0 592.1 648.1 709.4
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 19.9 26.2 27.6 31.1 41.1
Account Receivables, % 6.5 7.4 7.55 7.73 8.53
Inventories 17.4 21.2 18.0 17.0 7.7 23.7 25.9 28.3 31.0 34.0
Inventories, % 5.68 5.98 4.9 4.24 1.6 4.48 4.48 4.48 4.48 4.48
Accounts Payable 7.5 10.6 6.9 12.0 17.4 14.7 16.1 17.6 19.3 21.1
Accounts Payable, % 2.46 2.98 1.89 2.98 3.61 2.78 2.78 2.78 2.78 2.78
Capital Expenditure -1.1 -1.2 -.5 -.4 -.1 -1.0 -1.1 -1.2 -1.3 -1.5
Capital Expenditure, % -0.35499 -0.34984 -0.12815 -0.10277 -0.02881576 -0.19291 -0.19291 -0.19291 -0.19291 -0.19291
Tax Rate, % 14.79 14.79 14.79 14.79 14.79 14.79 14.79 14.79 14.79 14.79
EBITAT 90.1 103.3 109.3 95.7 91.4 139.0 152.2 166.6 182.3 199.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 61.4 97.3 110.0 100.8 97.0 124.0 150.1 164.3 179.8 196.8
WACC, % 6.6 6.6 6.6 6.6 6.6 6.6 6.6 6.6 6.6 6.6
PV UFCF
SUM PV UFCF 666.2
Long Term Growth Rate, % 3.50
Free cash flow (T + 1) 204
Terminal Value 6,575
Present Terminal Value 4,777
Enterprise Value 5,443
Net Debt -135
Equity Value 5,579
Diluted Shares Outstanding, MM 112
Equity Value Per Share 49.92

What You Will Get

  • Real CORT Financial Data: Pre-filled with Corcept Therapeutics' historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Corcept Therapeutics' intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • 🔍 Real-Life CORT Financials: Pre-filled historical and projected data for Corcept Therapeutics Incorporated (CORT).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Corcept’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Corcept’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Corcept Therapeutics data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Corcept Therapeutics’ intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Corcept Therapeutics Incorporated (CORT)?

  • All-in-One Solution: Features DCF, WACC, and financial ratio analyses tailored for Corcept Therapeutics.
  • Flexible Inputs: Modify yellow-highlighted cells to explore different financial scenarios for (CORT).
  • In-Depth Analysis: Automatically computes Corcept's intrinsic value and Net Present Value.
  • Preloaded Information: Historical and projected data provide reliable starting points for (CORT).
  • High-Quality Standards: Perfect for financial analysts, investors, and business consultants focusing on (CORT).

Who Should Use This Product?

  • Individual Investors: Gain insights to make informed decisions regarding Corcept Therapeutics stock (CORT).
  • Financial Analysts: Enhance valuation processes with comprehensive financial models tailored for Corcept Therapeutics.
  • Consultants: Provide clients with accurate and timely valuation insights related to Corcept Therapeutics.
  • Business Owners: Learn about the valuation of biopharmaceutical companies like Corcept to inform your own business strategy.
  • Finance Students: Explore real-world data and scenarios to master valuation techniques using Corcept Therapeutics as a case study.

What the Template Contains

  • Pre-Filled Data: Contains Corcept Therapeutics' historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model with real-time calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC using customized inputs.
  • Key Financial Ratios: Evaluate Corcept's profitability, efficiency, and leverage metrics.
  • Customizable Inputs: Easily modify revenue growth rates, margins, and tax assumptions.
  • Clear Dashboard: Visuals and tables summarizing critical valuation outcomes.

No products were found matching.